People taking the pills lost almost as much weight as those taking the injectable version of the drug
GHK-Cu works through different mechanisms Wnt pathway activation, anti-inflammatory signaling, reduced androgen receptor sensitivity but it doesn't directly block DHT the way finasteride does, and it doesn't open potassium channels like minoxidil
In brief, this study shows that GLP-1 signaling promotes improved blood flow to the heart in a simulated heart attack. Andrew Adelsheimer, MD The specific mechanism is that GLP-1 receptors are present on coronary capillary cells (pericytes) and activate signaling via energy-dependent potassium channels (K ATP channels) to promote This is a potential explanation for the observed benefit of GLP-1 receptor agonists in reducing cardiovascular adverse events
Less common adverse events in this meta-analysis were weight loss, infections, nausea, dysphagia, lethargy, headache, abdominal pain, irregular menstruation, drowsiness, and kidney stones
We do have small early human data measuring semaglutide in breast milk